{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:23:28Z","timestamp":1787498608797,"version":"build-2736575974"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018911","name":"University Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000264","name":"Canadian Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cld.2026.04.012","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:23:14Z","timestamp":1780658594000},"page":"791-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis after Liver Transplantation"],"prefix":"10.1016","volume":"30","author":[{"given":"Yu Jun","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan Sen","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-7980","authenticated-orcid":false,"given":"Aldo J.","family":"Montano-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cld.2026.04.012_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70190","article-title":"Pathogenesis, non-invasive assessments and treatment of hepatic fibrosis in autoimmune liver diseases","volume":"45","author":"Lytvyak","year":"2025","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.dld.2025.02.001","article-title":"PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation","volume":"57","author":"Lytvyak","year":"2025","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib3","doi-asserted-by":"crossref","first-page":"E665","DOI":"10.1503\/cjs.012121","article-title":"Trends in liver transplantation for autoimmune liver diseases: a Canadian study","volume":"65","author":"Murillo Perez","year":"2022","journal-title":"Can J Surg"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2025.03.025","article-title":"Global epidemiology of primary biliary cholangitis: an updated systematic review and meta-analysis","volume":"24","author":"Tan","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2026.04.012_bib7","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/ibd\/izad276","article-title":"Incidence and prevalence of primary sclerosing cholangitis: a meta-analysis of population-based studies","volume":"30","author":"Cooper","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.cld.2026.04.012_bib8","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.cgh.2020.06.062","article-title":"Definition and management of patients with primary biliary cholangitis and an incomplete response to therapy","volume":"19","author":"Montano-Loza","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10457","key":"10.1016\/j.cld.2026.04.012_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","article-title":"Primary sclerosing cholangitis. Primary sclerosing cholangitis","volume":"11","author":"Manns","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.cld.2026.04.012_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"Meld 3.0: the model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.012_bib16","doi-asserted-by":"crossref","first-page":"S-1554","DOI":"10.1016\/S0016-5085(24)04023-X","article-title":"633 recompensation is uncommon following index decompensation in patients with decompensated primary biliary cholangitis","volume":"166","author":"Wong","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2026.04.012_bib17","article-title":"Prevalence and clinical outcomes of recompensation in decompensated cirrhosis: a systematic review and meta-analysis","volume":"22","author":"Goh","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14527","article-title":"Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation","volume":"36","author":"Zhou","year":"2022","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100742","article-title":"Waitlist mortality in patients with autoimmune liver diseases","volume":"27","author":"Goyes","year":"2022","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.04.012_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11729","article-title":"Liver transplantation for primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD)-A European Society of Organ transplantation (ESOT) consensus statement","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.cld.2026.04.012_bib22","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/TXD.0000000000000548","article-title":"Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway","volume":"1","author":"Andersen","year":"2015","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2026.04.012_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.cld.2026.04.012_bib27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2024.05.010","article-title":"Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation","volume":"81","author":"Montano-Loza","year":"2024","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2026.04.012_bib29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond","volume":"34","author":"Visseren","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16214","article-title":"Outcome of liver retransplantation in patients with primary sclerosing cholangitis","volume":"45","author":"Molinaro","year":"2025","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/LVT.0000000000000419","article-title":"Recurrence of autoimmune liver diseases after liver transplantation: review and expert opinion statement","volume":"31","author":"Montano-Loza","year":"2025","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2026.04.012_bib32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.cld.2026.04.012_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2026.04.012_bib35","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2026.04.012_bib38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/LVT.0000000000000374","article-title":"Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: an intention-to-treat analysis","volume":"30","author":"Jones","year":"2024","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0168-8278(95)80033-6","article-title":"Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis","volume":"23","author":"Dubel","year":"1995","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/jaut.1997.0156","article-title":"Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis","volume":"10","author":"Mattalia","year":"1997","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.cld.2026.04.012_bib45","article-title":"Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study","volume":"6","author":"van Hooff","year":"2024","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib48","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2025.09.024","article-title":"Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis","volume":"84","author":"Wong","year":"2026","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2026.04.012_bib50","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2026.04.012_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000798","article-title":"High biochemical remission rates in patients with primary biliary cholangitis treated with \"triple\" anticholestatic therapy","volume":"9","author":"Cancado","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2026.04.012_bib52","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1016\/S0168-8278(24)01095-X","article-title":"Second-line treatment in recurrent primary biliary cholangitis after liver transplantation: an international multicentre study","volume":"80","author":"Abbas","year":"2024","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2026.04.012_bib53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the adult-to-adult living donor liver transplantation cohort study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.14309\/ajg.0000000000002977","article-title":"Severe cholestasis predicts recurrent primary sclerosing cholangitis following liver transplantation","volume":"120","author":"Aziz","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib57","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s11845-023-03586-1","article-title":"Recurrent sclerosing cholangitis post-transplant: increased recurrence rates following re-transplantation","volume":"193","author":"Falco","year":"2024","journal-title":"Ir J Med Sci"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib58","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib59","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0041-1345(99)00256-0","article-title":"Increased bile duct complications and\/or chronic rejection in crossmatch positive human liver allografts","volume":"31","author":"Takaya","year":"1999","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cld.2026.04.012_bib62","first-page":"190a","article-title":"Donation after cardiac death (DCD) liver transplantation does not impact patient or graft survival in primary sclerosing cholangitis (PSC)","volume":"64","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib63","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/TP.0000000000000447","article-title":"Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution","volume":"99","author":"Sundaram","year":"2015","journal-title":"Transplantation"},{"issue":"15","key":"10.1016\/j.cld.2026.04.012_bib64","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation - a randomized trial","volume":"384","author":"Van Rijn","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib65","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jceh.2020.02.002","article-title":"Good long-term outcomes in patients with primary sclerosing cholangitis undergoing living donor liver transplantation","volume":"10","author":"Choudhary","year":"2020","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12072-022-10442-4","article-title":"Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India","volume":"17","author":"Jadaun","year":"2023","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.cld.2026.04.012_bib67","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib68","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"28","key":"10.1016\/j.cld.2026.04.012_bib69","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3748\/wjg.v24.i28.3171","article-title":"Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients","volume":"24","author":"Buchholz","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.23827","article-title":"Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy","volume":"20","author":"Sutton","year":"2014","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana","year":"2015","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.cld.2026.04.012_bib72","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib73","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/SLA.0000000000006533","article-title":"Long-term outcomes following colectomy and liver transplantation for inflammatory bowel disease with primary sclerosing cholangitis","volume":"283","author":"Matar","year":"2026","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10151-024-02976-6","article-title":"Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis","volume":"28","author":"Schabl","year":"2024","journal-title":"Tech Coloproctol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib76","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib77","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/TP.0000000000000447","article-title":"Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution","volume":"99","author":"Sundaram","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2026.04.012_bib78","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation: a French national cohort study including 571 patients","author":"Veyre","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib79","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib80","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib81","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2026.04.012_bib82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2026.04.012_bib83","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MCG.0000000000001271","article-title":"Increased posttransplant mortality for autoimmune hepatitis compared with other autoimmune liver diseases","volume":"54","author":"Lee","year":"2020","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib84","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2026.04.012_bib85","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2026.04.012_bib86","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.cld.2026.04.012_bib87","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2026.04.012_bib88","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation - is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2026.04.012_bib89","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s11605-009-0898-3","article-title":"Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis","volume":"13","author":"Kashyap","year":"2009","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.cld.2026.04.012_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2026.04.012_bib91","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/HEP.0000000000001268","article-title":"Liver transplantation for cholestatic liver diseases: timing and disease recurrence","volume":"82","author":"Cancado","year":"2025","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:35:23Z","timestamp":1784763323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1089326126000462"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.012","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis after Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}